Clinical Trial: A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07898189) titled 'A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users' on Oct. 21.

Brief Summary: This is a randomized, triple-blind, placebo-controlled, virtual clinical trial evaluating the effects of the Oxxynea(R) botanical supplement on gut comfort in adults who use GLP-1 receptor agonists (GLP-1 RAs). Seventy participants experiencing gastrointestinal discomfort associated with GLP-1 RA use will be randomized to receive either Oxxynea(R) or a matching placebo once daily for six weeks.

Participants will complete questionnaires at Baseline, daily for the first 14 days, and at the end of Weeks 2, 4, and ...